Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Sai Lan Liu"'
Autor:
Li Yuan, Guo-Dong Jia, Xiao-Fei Lv, Si-Yi Xie, Shan-Shan Guo, Da-Feng Lin, Li-Ting Liu, Dong-Hua Luo, Yi-Fu Li, Shen-Wen Deng, Ling Guo, Mu-Sheng Zeng, Xiu-Yu Cai, Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Su-Chen Li, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Immunotherapy combined with antiangiogenic targeted therapy has improved the treatment of certain solid tumors, but effective regimens remain elusive for refractory recurrent/metastatic nasopharyngeal carcinoma (RM-NPC). We conducted a phase
Externí odkaz:
https://doaj.org/article/27667fc2633a47359b998b866e9c4201
Autor:
Dong-Hua Luo, Xiao-Yun Li, Shan-Shan Guo, Wan-Ping Guo, Li-Ting Liu, Hao-Yuan Mo, Ling Guo, Xiao-Fei Lv, Li-Zhi Liu, Ji-Bin Li, Qing Liu, Pan Wang, Xue-Song Sun, Sai-Lan Liu, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 40, Iss , Pp 100895- (2023)
Summary: Background: Previous studies demonstrated that induction chemotherapy (IC) followed by de-escalated chemoradiotherapy adapted to tumor response was effective in treating childhood nasopharyngeal carcinoma (NPC), but the toxicity profile of t
Externí odkaz:
https://doaj.org/article/fb7b6b29c54f415da4ab3124c69dc6d0
Autor:
Guo-Dong Jia, Xue-Song Sun, Xiao-Yun Li, Sai-Lan Liu, Jin-Hao Yang, Qiu-Yan Chen, Li Yuan, Hai-Qiang Mai
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Objective We compared the clinical characteristics and survival outcomes after radical radiotherapy between nasopharyngeal carcinoma (NPC) with early and late metastases based on a relatively large cohort, which provides valuable data for th
Externí odkaz:
https://doaj.org/article/1410bcd9097d4f8c8a048374317af5f4
Autor:
Sai-Lan Liu, Xiao-Yun Li, Xue-Song Sun, Jing-Yun Peng, Chao Lin, Jin-Jie Yan, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Li-Ting Liu, Hai-Qiang Mai
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Purpose To analyze the clinical outcomes of patients with regional persistent/recurrent nasopharyngeal carcinoma (NPC) who received neck dissection, and to evaluate the clinical benefit of postoperative adjuvant therapy (PAT) based on patien
Externí odkaz:
https://doaj.org/article/8526add604294940b4931849109b754b
Autor:
Hui-Zhi Qiu, Xu Zhang, Sai-Lan Liu, Xue-Song Sun, Yi-Wen Mo, Huan-Xin Lin, Zi-Jian Lu, Jia Guo, Lin-Quan Tang, Hai-Qiang Mai, Li-Ting Liu, Ling Guo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Purpose: To establish a risk classification of de novo metastatic nasopharyngeal carcinoma (mNPC) patients based on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET-CT) radiomics parameters to identify suitable
Externí odkaz:
https://doaj.org/article/648a8b7fb12f44a4b52cd0d08c5cc22e
Autor:
Zhen-Chong Yang, Ting Liu, Yan-Zhou Chen, Chun-Yan Guo, Li-Ting Liu, Sai-Lan Liu, Qiu-Yan Chen, Hai-Qiang Mai, Shan-Shan Guo
Publikováno v:
Cancer Control, Vol 29 (2022)
Background The combined use of immune checkpoint inhibitors (ICIs) with palliative chemotherapy (PCT) is a promising first-line treatment for de novo metastatic nasopharyngeal carcinoma (mNPC). However, the efficacy of ICIs with PCT vs PCT with defin
Externí odkaz:
https://doaj.org/article/51792a83ad574c3491e8267abbac9b33
Autor:
Xue‐Song Sun, Bei‐Bei Xiao, Chao Lin, Sai‐Lan Liu, Qiu‐Yan Chen, Lin‐Quan Tang, Hai‐Qiang Mai
Publikováno v:
Cancer Medicine, Vol 9, Iss 5, Pp 1661-1670 (2020)
Abstract Objective We aimed to establish and validate two nomograms that predict progression‐free survival (PFS) and overall survival (OS) in patients with stage II–IVa nasopharyngeal carcinoma (NPC) while evaluating the benefit of concurrent che
Externí odkaz:
https://doaj.org/article/7edb6e4a93174cd493250bb670d3fb36
Autor:
Sai-Lan Liu, Xue-Song Sun, Hao-Jun Xie, Qiu-Yan Chen, Huan-Xin Lin, Hu Liang, Yu-Jing Liang, Xiao-Yun Li, Jin-Jie Yan, Chao Lin, Zhen-Chong Yang, Shan-Shan Guo, Li-Ting Liu, Qing-Nan Tang, Yu-Yun Du, Lin-Quan Tang, Ling Guo, Hai-Qiang Mai
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background We compared the efficacy and toxicity of three IC regimens (TPF: taxanes, cisplatin, and 5-fluorouracil; TP: taxanes and cisplatin; and PF: cisplatin and 5-fluorouracil) followed by CCRT in locoregionally advanced NPC. Methods The
Externí odkaz:
https://doaj.org/article/eb027476d81c4c98a703d19a403b9f74
Autor:
Xue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, Qiu-Yan Chen, Shan-Shan Guo, Yue-Feng Wen, Li-Ting Liu, Hao-Jun Xie, Qing-Nan Tang, Xiao-Yun Li, Jin-Jie Yan, Lin-Quan Tang, Hai-Qiang Mai
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background This study aimed to evaluate the prognostic value of maximal standard uptake values (SUVmax) of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (PET) comparing with Epstein-Barr virus (EBV) DNA levels in de novo metastat
Externí odkaz:
https://doaj.org/article/e6e43d2dcfa546a0b8e5d7b209a99fba
Autor:
Shan-Shan Guo, Yu-Jing Liang, Li-Ting Liu, Qiu-Yan Chen, Yue-Feng Wen, Sai-Lan Liu, Xue-Song Sun, Qing-Nan Tang, Xiao-Yun Li, Hai-Qiang Mai, Lin-Quan Tang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Despite the development of such multiple therapeutic approaches, approximately 20% patients experience recurrence. Identification of molecular markers for stratifying the different risks of tumour recurrence and progression is considered
Externí odkaz:
https://doaj.org/article/252c3bf4050142b9bd09d104039d128c